Objective: To evaluate whether or not the liquid-based procedure (LBP) for endometrial cytology is as worthwhile for endometrial phasing as conventional slides. Materials and Methods: The subjects were 81 women who underwent endometrial cytology and were defined as negative. The specimens obtained by either Endocyte® or Masubuchi aspiration tube® were processed first with the conventional procedure and then with LBP using TACAS™. Results: (1) The number of subjects diagnosed by the conventional method as having proliferative, mid-, middle-secretory and late-secretory and atrophic phases was 40, 11, 10, 0 and 20, respectively. The rate of agreement with those using LBP was 87.7%. (2) Incidences of large clusters, ductal clusters, palisade arrangement, uneven staining and dirty mucous background detected were significantly higher with the conventional method, whereas with LBP clean background, inconspicuous bonding of cells, scattered solitary glandular cells, clear well-stained cytoplasm and cell compactness were higher. (3) Especially in the proliferative phase, clusters tended to be smaller and lose their architectural structures, and scattered solitary columnar cells were present. (4) Cells in the mid-phase tended to have loose contact and to mimic other phases. Conclusions: Cytodiagnosis of endometrial phasing prepared with LBP is feasible to perform when some modifications are implemented.

Keywords:
Endometrial cytology, Normal endometrium, Endometrial phasing, Menstrual phase, Liquid-based procedure, TACAS
1.
Nakagawa-Okamura C, Sato S, Tsuji I, Kuramoto H, Tsubono Y, Aoki D, Jobo T, Oomura M, Hisamichi S, Yajima A: Effectiveness of mass screening for endometrial cancer. Acta Cytol 2002;46:277-283.
2.
Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-17.
3.
Jobo T, Tateoka K, Kuramoto H: Study on the long term follow-up of endometrial hyperplasia. Int J Clin Oncol 1996;1:163-169.
4.
Kurman RJ, Kaminski PF, Norris HJ: A long-term study of ‘untreated' hyperplasia in 170 patients. Cancer 1985;56:403.
5.
Namce KV: Evolution of Pap testing at a community hospital: a ten-year experience. Diag Cytopathol 2007;35:148-153.
6.
Akamatsu S, Himeji Y, Ikuta N, Shimagaki N, Maruoka H, Kodama S: Satisfactoriness and disease detection in the screening specimens of cervical cancer - comparison between liquid-based and conventional methods. Jpn J Clin Cytol 2008;47:420-424 (in Japanese).
7.
Hutchinson ML, Isenstein LM, Goodman A, Hurley AA, Douglas KL, Mui KK: Homogenous sampling accounts for the increased diagnostic accuracy using the ThinPrep® processor. Am J Clin Pathol 1994;101:215-219.
8.
Lee KR, Ashfaq R, Birdsong GG, Corkill ME, McIntosh KM, Inborn SL: Comparison of conventional Papanicolaou smears and fluid-based, thin-layer system for cervical cancer screening. Obstet Gynecol 1997;90:278-284.
9.
Hatch KD, Sheets E, Kennedy A, Ferris DG, Darragh T, Twiggs L: Multicenter direct-to-vial evaluation of a liquid-based Pap test. J Lower Gen Tract Dis 2004;8:308-312.
10.
Park J, Jung EH, Kim C, Choi YH: Direct-to-vial comparison of a new liquid-based cytology system, liquid-PREP versus the conventional Pap smear. Diag Cytopathol 2007;35:488-492.
11.
Kuramoto H, Iwami Y, Sugimoto N, Kato C, Sugahara T, Iida M: Application of a new liquid-based procedure (TACAS) for the screening of cervical cancer: a preliminary study. Acta Cytol 2012;56:74-79.
12.
Kuramoto H, Banno M, Hori M, Miyagawa J, Iida M, Kawaguchi M: Optimal sampling devices for liquid-based procedure in screening for cervical cancer - comparison between cotton stick/Cytobrush and Cervex-Brush. Acta Cytol 2013;57:153-158.
13.
Kuramoto H, Sugimoto N, Iwami Y, Kato C, Hori M, Iida M: Evaluation of a new automated processing system (TACAS™ Pro) for liquid-based procedures. Acta Cytol 2015;59:207-212.
14.
Kuramoto H, Nishimura Y, Watanabe J: Endometrial cytology; in: Atlas of Thin-Layer Specimens (in Japanese). Nagoya, Medical and Biological Laboratory Co. Ltd., 2005, pp 43-75.
15.
Norimatsu Y, Kouda H, Kobayashi TK, et al: Utility of thin-layer preparations in the endometrial cytology: Evaluation of benign endometrial lesions. Ann Diag Pathol 2008;12:103-111.
16.
Watanabe J, Nishimura Y, Tsunoda S, Kawaguchi M, Okayasu I, Kuramoto H: Liquid-based preparation for endometrial cytology - usefulness for predicting the prognosis of endometrial carcinoma preoperatively. Cancer Cytopathol 2009;117:254-263.
17.
Norimatsu Y, Kouda H, Kobayashi TK, Shimizu K, Yanoh K, Tsukayama C, Miyake Y, Ohno E: Utility of liquid-based cytology in endometrial pathology: diagnosis of endometrial carcinoma. Cytopathol 2009;20:395-402.
18.
Norimatsu Y, Yanoh K, Kobayashi TK: The role of liquid-based preparation in the evaluation of endometrial cytology. Acta Cytol 2013;57:423-435.
19.
Norimatsu Y, Shigematsu Y, Sakamoto S, Ohsaki H, Yanoh K, Kawanishi N, Kobayashi TK: Nuclear characteristics of the endometrial cytology: liquid-based versus conventional preparation. Diag Cytopathol 2013;41:120-125.
20.
Yanoh K, Norimatsu Y, Munakata S, Yamamoto T, Nakamura Y, Murata T, Kobayashi TK, Hirai Y: Evaluation of endometrial cytology prepared with the Becton Dickinson SurePath™ method: a pilot study by the Osaki study group. Acta Cytol 2014;58:153-161.
21.
Kuramoto H: Color Atlas: Screening of Endometrial Cancer (in Japanese). Tokyo, Ishiyaku Publishing, 1988, pp 36-37, pp 58-61.
22.
JSCC Atlas and Guidelines for Cytopathological Diagnosis (in Japanese). Tokyo, Kanehara-shuppan, 2015, pp 71-73, pp 93-94.
23.
Hirai Y, Ynoh K, Norimatsu Y (eds): Atlas of Endometrial Cytology (in Japanese). 2015, pp 31-46.
24.
Hayashi R: Nucleometry of the normal and neoplastic endometrial cells. J Jpn Soc Clin Cytol 1992;31:457-465.
25.
Morisawa T, Kuramoto H, Ohno E, Imai T: Cytological feature of adenomatous hyperplasia of the endometrium. J Jpn Soc Clin Cytol 1991;30:15-20.
26.
Ohkawara S, Jobo T, Sato R, Kuramoto H: Comparison of endometrial carcinoma coexisting with and without endometrial hyperplasia. Euro J Gynecol Oncol 2000;21:573-577.
27.
Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H: Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus. Usefulness and limitations. Euro J Gynecol Oncol 2001;22:217-220.
28.
Hayashi R, Kuramoto H: Endometrial cytology of dysfunctional uterine bleeding - retrospective study on suspicious cases. J Jpn Soc Clin Cytol 2002;41:201-208.
29.
Sherman ME, Mazur MT, Kurman RJ: Dysfunctional uterine bleeding; in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract, ed 5. New York, Springer, 2002, pp 413-437.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.